Doctors in China — Page 4

Dr. Wang Jun is a Provincial Medical Leading Talent and professor at Xiamen Humanity Hospital. He is a primary expert in cardiac and osteoporosis rehabilitation. Dr. Wang specializes in integrated Chinese–Western care for complex geriatric conditions. He focuses on atherosclerosis reversal and stroke prevention.

• Identified as a Provincial Medical Leading Talent in Fujian.
• Serves as Deputy Director for several regional geriatrics and rehabilitation branches.
• Specializes in reversing diabetes and managing post-infarction care.
• Works at a tertiary hospital treating 1,000,000 patients annually.

Dr. Yu Chang Ying is a recognized stomatology expert at Xiamen Humanity Hospital. He is officially designated as a Renowned Expert in Fujian Province. Dr. Yu specializes in dental implants and oral tumors. He treats complex oral and maxillofacial trauma in emergency settings. The doctor serves as a Vice President of the Xiamen Stomatological Association.

• Performs dental implantation and fits implant-supported prostheses.
• Treats oral inflammatory diseases, salivary gland disorders, and congenital deformities.
• Serves as Deputy Director of the Fujian Medical Association Oral Mucosal Diseases Committee.
• Practices at a tertiary hospital treating 1,000,000 patients annually.

Dr. Yan Zhi Ping serves as Director of Radiology at Xiamen Humanity Hospital. He specializes in the early diagnosis of lung cancer and brain tumors. Dr. Yan has published over 30 academic papers and edited several professional monographs. He received the Fujian Provincial Third Prize for Science and Technology Progress.

• Identifies diseases of the central nervous system, musculoskeletal system, and abdomen.
• Expert in CT, MRI, and cerebral functional imaging.
• Vice Chairman of both the Xiamen Radiological Society and the Xiamen Medical Doctor Association.
• Practices at a tertiary hospital featuring mainland China's first BNCT center.

Dr. Zhang Jin Nong is a national expert in infectious diseases at Xiamen Humanity Hospital. He serves as Director of Respiratory and Cardiovascular Medicine. Dr. Zhang received the Hubei Provincial Advanced Individual award for his pandemic control efforts. He treats complex cases of lung cancer, pneumonia, and chronic obstructive pulmonary disease.

• Specializes in fiberoptic bronchoscopy and both invasive and non-invasive ventilation.
• Treats sleep-disordered breathing and performs detailed pulmonary function testing.
• Serves as Deputy Director of the Infectious Diseases Group for the Chinese Medical Doctor Association.
• Holds a leadership role in the Sleep Medicine Branch of the Chinese Stroke Association.

Dr. You Deming serves as Director of the Traditional Chinese Medicine Department at Xiamen Humanity Hospital. He is a standing committee member of the Pediatric Tuina Development Consortium in China. Dr. Deming graduated from the Anhui University of Traditional Chinese Medicine. He previously practiced at the Bengbu First People's Hospital.

• Specializes in pediatric Tuina therapy and common childhood disorders.
• Treats complex internal medicine conditions, including rheumatic disorders and diabetes.
• Expert in TCM gynecology and infertility treatments.
• Practices at a tertiary hospital that treats 1,000,000 patients annually.

Dr. Chen Ling is a pediatric neurologist at Xiamen Humanity Hospital. She holds a standing council seat at the Fujian Anti-Epilepsy Association. Dr. Chen graduated from Shanghai Jiao Tong University School of Medicine. She previously practiced at The First Affiliated Hospital of Xiamen University.

• Treats childhood epilepsy, developmental delays, and tic disorders.
• Manages ADHD, intracranial infections, and peripheral nerve disorders.
• Completed pediatric neurology training at Shanghai Xinhua Hospital.
• Sits on the Fujian Alliance of Pediatric and Adolescent Psychiatrists council.

Dr. Wei Wei directs the Hepatobiliary and Pancreatic Surgery Department at Xiamen Humanity Hospital. He specializes in ultra-minimally invasive surgery for liver and pancreatic conditions. Dr. Wei performs single-port laparoscopic cholecystectomy for gallbladder stones and polyps. He also provides conversion therapy for advanced liver cancer cases.

• Specializes in laparoscopic hepatectomy for benign liver tumors.
• Treats complex conditions including hepatolithiasis and biliary tract tumors.
• Member of the Colorectal Cancer Committee Metastasis Group under the Fujian Anti-Cancer Association.
• Serves in the Surgery Branch of the Xiamen Medical Association.

Dr. Huang Wen Qi is a national liver disease consulting expert at Xiamen Humanity Hospital. He focuses on antiviral therapy and clinical cures for chronic hepatitis B. He combines traditional Chinese and Western medicine to treat complex liver conditions. Dr. Huang provides artificial liver support including plasma exchange and dual bilirubin adsorption.

• Council Director for the Specialized Alliance of Liver and Infectious Diseases.
• Executive Committee member of the China Liver Failure Blood Purification Project.
• Treats liver failure, cirrhosis, fatty liver, and autoimmune hepatitis.
• Performs minimally invasive diagnosis and specialized liver fibrosis assessments.

Dr. Xu Juntang, MD, is a Postdoctoral Fellow, Chief Physician, and Master’s Supervisor. He is the Director of Cardiovascular Medicine at Xiamen Humanity Hospital. His work focuses on preventing and treating cardiovascular and thrombotic diseases, including coronary artery disease, hypertension, heart failure, arrhythmias, and emergencies. He is skilled in cardiovascular biomarker testing.

He provides standardized care for thromboembolism related to valvular heart disease and non‑valvular atrial fibrillation, pulmonary embolism, deep vein thrombosis, and obstetric thrombophilia. He also conducts clinical and laboratory assessments of thrombosis and coagulation disorders. He is the Vice Chairman of the Laboratory and Clinical Branch of the Chinese Society of Cardiothoracic and Vascular Anesthesiology.

Professor Fan Jun Hua is the Director of Ophthalmology at Xiamen Humanity Hospital. He has more than 20 years of clinical experience. He focuses on corneal and ocular surface disease, glaucoma, cataracts, and eye trauma. He previously led the Ophthalmology Ward at the 180th Hospital of the PLA Ophthalmology Center. He received the Military Medical and Health Outstanding Talent Position Allowance.

Dr. Fan has published over 50 papers and led three military or regional projects. His honors include two Third-Class Military Scientific and Technological Progress Awards, two Third-Class Military Medical Achievement Awards, and two Quanzhou Science and Technology Progress Awards. He was named one of Quanzhou’s Top Ten Outstanding Health Guardians. He is recognized as a Distinguished Ophthalmology Expert by the Nanjing Military Area Command and by Fujian Province.

Dr. Li Huaifang specializes in gynecologic tumors, pelvic floor disorders, and minimally invasive gynecologic surgery. She has performed over 10,000 minimally invasive procedures and more than 5,000 pelvic floor repairs. Her work includes laparoscopic and hysteroscopic cancer operations. She also performs reconstructive surgery for prolapse and incontinence. She has demonstrated surgical techniques at national conferences.

Academic roles: National member, Pelvic Floor Dysfunction Group (CMA OBGYN). Deputy head, Shanghai MA OBGYN Pelvic Floor Group. Expert, Shanghai Gynecologic Quality Control Panel. She joined the 12th Five-Year Plan. She now leads a 14th Five-Year Plan sub-project on degradable pelvic floor meshes. Publications: 240+ papers, including 50+ SCI. Textbook co-author and supervisor at Tongji University with 50+ mentees. Honors include the Shanghai Medical S&T Award, the Chinese MCH S&T Award, and prizes for pelvic floor reconstruction in 2006, 2012, and 2015.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Wang Qi is an Attending Physician in Traditional Chinese Medicine. She completed standardized residency training at Qinhuangdao Hospital of Traditional Chinese Medicine from 2019 to 2024. She has practiced at Panacee Hospital since 2024.

She is skilled in observation, listening, inquiry, and palpation. She applies careful syndrome differentiation and follows standard clinical treatment protocols.

Her clinical focus includes subhealth management, endocrine imbalance, chronic fatigue, sleep disorders, digestive disorders, and women’s health regulation. She provides individualized herbal regimens with lifestyle guidance. She also works with multidisciplinary teams to deliver integrated Chinese–Western care.

Dr. Liu De is the Implant Director at Wuhan Yiya Simei Dental Hospital. He also practices at the Shanghai Yingbo Dental Bund Flagship Store. He earned a Doctor of Stomatology in 2014 from the West China School of Stomatology, Sichuan University. He has been licensed since August 27, 2015. He is Nobel Biocare SFA certified and an Italy B&B Implant System certified clinician.

Focus: full- and half-mouth rehabilitation; minimally invasive immediate implants and immediate loading; All-on-4 and All-on-6; bone augmentation and free autologous grafting; maxillary sinus lift; socket preservation; zygomatic implants; hybrid implant-supported dentures; aesthetic restorations and custom crowns; precision removable dentures.

Achievements: former Associate Professor at Guizhou Medical University. He has long experience in clinical teaching and research. He has trained many implant dentists. He speaks regularly at national stomatology conferences. He has extensive experience with complex edentulous cases and severe alveolar atrophy.

Dr. Qin Jie is a licensed internal medicine physician. She has practiced since 2016. She has broad experience in community and general hospitals. She now works at Panacee Hospital (since June 2026). Her focus includes internal medicine diagnosis, sub-health assessment, and comprehensive health management.

She worked at Changli Great Wall Hospital (Oct 2016–Sep 2020). She then served at Anaya Community Hospital (Sep 2020–Nov 2024). She worked at Panacee Hospital (Dec 2024–Nov 2025 and Jun 2026–present). She also served at Weiyuan Hospital (Nov 2025–Jun 2026).